Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19
Abstract Background The impact of prior exposure to systemic corticosteroids on COVID-19 severity in patients hospitalized for a SARS-CoV-2 pneumonia is not known. The present study was designed to answer to this question. Methods The population study was the Covid-Clinic-Toul cohort which records d...
Main Authors: | Margaux Lafaurie, Guillaume Martin-Blondel, Pierre Delobel, Nassim Kamar, Sandrine Charpentier, Agnès Sommet, Guillaume Moulis, and the Covid-Clinic-Toul investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | BMC Pharmacology and Toxicology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40360-021-00480-3 |
Similar Items
-
National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018
by: Allan Klitgaard, et al.
Published: (2024-02-01) -
Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study
by: Berge LAM, et al.
Published: (2020-12-01) -
Pharmacoepidemiology /
by: Strom, Brian L.
Published: (2005) -
TOPICAL CORTICOSTEROIDS IN ORAL PATHOLOGY
by: Adriana Krasteva, et al.
Published: (2010-12-01) -
Systemic toxicity of topical corticosteroids
by: Jitender Jinagal, et al.
Published: (2019-01-01)